Skip to content
Delivering innovative diagnostic cancer tests
What We Do?
What we do?
Cancer – how it works?
Transplantation – how it works?
Publications and Media
Board and Management
Scientific Advisory Board and Key Opinion Leaders
Amedes Group signs DNA testing licensing agreement with Chronix Biomedical Inc.
Chronix Biomedical: Study Results on Cell-Free DNA Test for Kidney Transplantation Presented at AACC
Chronix Biomedical Study Demonstrates Its Blood Test Can Predict Response to Cancer Immunotherapy
Chronix Biomedical: Changes in Tumor Cell-Free DNA Copy Number Instability (CNI) Predict Therapeutic Response to Immunotherapy
Chronix Biomedical: Changes in Tumor Cell-Free DNA Copy Number Instability (CNI) Predict Therapeutic Response in Metastatic Cancers
Chronix Biomedical to Present Clinical Data on Its Cell-Free DNA Approach as an Early Predictor of Response to Chemotherapy at the AACR Annual Meeting
Chronix Biomedical Files Patent Application on Liquid Biopsy
Chronix Biomedical AACR Investor Press Release